Phosphorylation of BRCA2 by the Polo-like kinase Plk1 is regulated by DNA damage and mitotic progression

MiYoung Lee1, Matthew J Daniels, Ashok R Venkitaraman

  • 1CR UK Department of Oncology and the Medical Research Council Cancer Cell Unit, Hutchison/MRC Research Centre, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK.

Oncogene
|December 3, 2003
PubMed

Insights

Researchers found that the breast cancer protein BRCA2 is phosphorylated by the mitotic kinase Plk1 during cell division. This Plk1-mediated BRCA2 modification is responsive to DNA damage and mitotic progression.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • BRCA2 is crucial for chromosomal stability and DNA repair.
  • Post-translational modifications of BRCA2 are not well understood.
  • Polo-like kinase 1 (Plk1) is a key regulator of mitosis.

Purpose of the Study:

  • To investigate the role of Plk1 in BRCA2 regulation.
  • To characterize the post-translational modification of BRCA2 by Plk1.

Main Methods:

  • Cell synchronization and treatment with RNA interference to deplete Plk1.
  • Co-immunoprecipitation to assess BRCA2-Plk1 interaction.
  • Analysis of BRCA2 phosphorylation sites within the BRC repeat region.

Main Results:

  • BRCA2 is phosphorylated by Plk1 during the G2/M cell cycle phases.
  • Plk1 depletion inhibits BRCA2 phosphorylation.
  • BRCA2 and Plk1 interact via a conserved region in BRCA2.
  • Plk1 phosphorylates residues between BRC repeats.
  • Adriamycin treatment inhibits Plk1-mediated BRCA2 phosphorylation.

Conclusions:

  • A regulatory circuit involving Plk1-mediated phosphorylation of BRCA2 is identified.
  • This circuit is sensitive to both mitotic progression and DNA damage.
  • Findings provide new insights into BRCA2 regulation and its role in maintaining genomic integrity.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart, a...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...